Statistical and pharmacometric modeling support for HIV nonvaccine biomedical prevention product development
Ended Awarded Last action
- Contract number
- 75N93019F00133
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $807,259
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 64% obligated
-
- $807,259.23 Current, with exercised options
- $1,261,199.23 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$17,380 | |
| Funding Only Action | -$77,915 | |
| Funding Only Action | -$158,045 | |
| Exercise an Option | $276,444 | |
| Exercise an Option | $268,834 | |
| Exercise an Option | $261,386 | |
| Other Administrative Action | $0 | |
| Original award | $253,935 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 1, 2019, with a ceiling value of $1,261,199.23 under the HIV Microbicides and Biomedical Prevention 2016–2021 parent IDIQ for statistical and pharmacometric modeling support for HIV nonvaccine biomedical prevention product development.
Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis and completed on August 31, 2023. No set-aside applied to this award.
Quick answers
Who was awarded contract 75N93019F00133?
75N93019F00133 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2019.
How much is contract 75N93019F00133 worth?
The government has obligated $807,259 on 75N93019F00133. Its potential value, with all options, is $1,261,199.
Is contract 75N93019F00133 an order under another contract?
Yes. 75N93019F00133 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93019F00133 competed?
The extent of competition for 75N93019F00133 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award